Video yükleniyor...

Video Yüklenemedi

Bu video yüklenirken bir sorun oluştu. Bu geçici bir ağ sorunundan kaynaklanıyor olabilir veya video kullanılamıyor olabilir.

Ana Sayfaya Dön

2. Multi-Omics & CRISPR Forget sick care. Precision medicine is here. • Diagnose cancer from a blood test • Cure sickle cell in one treatment • Edit your genes before symptoms appear ARK expects a $26T market in genomics and biotech.

Ken Berenger

11,958 subscribers

83,392 görüntüleme • 10 ay önce •via X (Twitter)

Sağlık & İyilik Bilim & Teknoloji

Anya Rossi• Live Now

Private livecam show

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

CATHIE WOOD SAYS: THE MOST UNDERESTIMATED PLACE FOR AI INNOVATION IS HEALTHCARE - AI will diagnose cancer from blood tests before symptoms appear - Pharma faces a $300B patent cliff in the next 5 years - That fear and caution is exactly where the opportunity is

CATHIE WOOD SAYS: THE MOST UNDERESTIMATED PLACE FOR AI INNOVATION IS HEALTHCARE - AI will diagnose cancer from blood tests before symptoms appear - Pharma faces a $300B patent cliff in the next 5 years - That fear and caution is exactly where the opportunity is

Ark Invest Tracker

101,696 görüntüleme • 3 ay önce

#WATCH | Chandrapur, Maharashtra: On National Sickle Cell Elimination Mission 2047 program, Director of ICMR- CRHCM, Nagpur Dr Manisha Madkaikar says, "The National Sickle Cell Elimination Mission has given the guidelines. One is universal screening. In areas with a very high prevalence of sickle cell disease, the entire population under 40 is screened. Currently, under this mission, it is planned that nearly 7 crore individuals will be screened for sickle cell disease... The other is newborn screening. As soon as a newborn is born, we can test the newborn to determine whether he has sickle cell disease. Newborn screening is important because if you diagnose newborns early, you can give them effective treatment... In antenatal screening, the first visit is an ideal time to screen a pregnant woman. If she is found to be a carrier or affected, we can test her partner. If both are carriers for sickle cell disease, we can counsel them about testing the fetus before 20 weeks' gestational age. If the fetus is affected, the couple can consider options regarding sickle cell disease and the decision about pregnancy termination is left solely to the patients and their family."

#WATCH | Chandrapur, Maharashtra: On National Sickle Cell Elimination Mission 2047 program, Director of ICMR- CRHCM, Nagpur Dr Manisha Madkaikar says, "The National Sickle Cell Elimination Mission has given the guidelines. One is universal screening. In areas with a very high prevalence of sickle cell disease, the entire population under 40 is screened. Currently, under this mission, it is planned that nearly 7 crore individuals will be screened for sickle cell disease... The other is newborn screening. As soon as a newborn is born, we can test the newborn to determine whether he has sickle cell disease. Newborn screening is important because if you diagnose newborns early, you can give them effective treatment... In antenatal screening, the first visit is an ideal time to screen a pregnant woman. If she is found to be a carrier or affected, we can test her partner. If both are carriers for sickle cell disease, we can counsel them about testing the fetus before 20 weeks' gestational age. If the fetus is affected, the couple can consider options regarding sickle cell disease and the decision about pregnancy termination is left solely to the patients and their family."

ANI

10,749 görüntüleme • 1 yıl önce

A groundbreaking new study published in Cancer Discovery reveals that certain cancers may be detectable in the blood up to three years earlier than current diagnostic methods allow. This could revolutionize early detection—and survival rates. Dr. Patrick Soon-Shiong, a pioneer in cancer research, breaks down the findings: "This study is a game-changer. By analyzing circulating tumor DNA (ctDNA)—genetic material shed by cancer into the bloodstream—researchers identified cancer mutations years before standard diagnosis. This isn’t just about early detection; it’s about monitoring recurrence post-treatment to catch metastasis before it spreads." Why This Matters: 🔹 Early Detection Saves Lives – The sooner cancer is found, the better the odds of successful treatment. 🔹 Peripheral Blood Holds the Key – The study highlights that simple blood tests (like cell-free DNA analysis) may outperform invasive biopsies and imaging for early signals. 🔹 Beyond Diagnosis – These tests could track survivors (like the patient mentioned) to ensure cancer doesn’t return silently. The Future? Imagine a world where routine blood work screens for cancer years before symptoms appear—turning a deadly disease into a manageable condition. This study brings us one step closer. "The answers aren’t just in high-tech scans—they’re in the peripheral blood we’ve overlooked for decades," says Dr. Soon-Shiong. "The era of precision prevention is here." Stay tuned. The fight against cancer just got smarter.

A groundbreaking new study published in Cancer Discovery reveals that certain cancers may be detectable in the blood up to three years earlier than current diagnostic methods allow. This could revolutionize early detection—and survival rates. Dr. Patrick Soon-Shiong, a pioneer in cancer research, breaks down the findings: "This study is a game-changer. By analyzing circulating tumor DNA (ctDNA)—genetic material shed by cancer into the bloodstream—researchers identified cancer mutations years before standard diagnosis. This isn’t just about early detection; it’s about monitoring recurrence post-treatment to catch metastasis before it spreads." Why This Matters: 🔹 Early Detection Saves Lives – The sooner cancer is found, the better the odds of successful treatment. 🔹 Peripheral Blood Holds the Key – The study highlights that simple blood tests (like cell-free DNA analysis) may outperform invasive biopsies and imaging for early signals. 🔹 Beyond Diagnosis – These tests could track survivors (like the patient mentioned) to ensure cancer doesn’t return silently. The Future? Imagine a world where routine blood work screens for cancer years before symptoms appear—turning a deadly disease into a manageable condition. This study brings us one step closer. "The answers aren’t just in high-tech scans—they’re in the peripheral blood we’ve overlooked for decades," says Dr. Soon-Shiong. "The era of precision prevention is here." Stay tuned. The fight against cancer just got smarter.

Camus

18,055 görüntüleme • 11 ay önce

Cats may help in the fight against cancer in humans Scientists analyzed nearly 500 samples from 13 types of cancer in domestic cats and decoded their genomes. They compared tumor tissue with healthy tissue and found mutations that match those seen in humans — including in the TP53 gene, one of the key genes involved in cancer development. This matters because cats live in the same environment as people and develop similar diseases. Their genome can be used to test new treatment methods — first in veterinary medicine and later in human medicine. This approach is known as “One Medicine,” where science benefits both animals and humans. Research into feline cancer could accelerate the search for new therapies and help scientists better understand how tumors develop in humans. The video is for illustrative purposes.

Cats may help in the fight against cancer in humans Scientists analyzed nearly 500 samples from 13 types of cancer in domestic cats and decoded their genomes. They compared tumor tissue with healthy tissue and found mutations that match those seen in humans — including in the TP53 gene, one of the key genes involved in cancer development. This matters because cats live in the same environment as people and develop similar diseases. Their genome can be used to test new treatment methods — first in veterinary medicine and later in human medicine. This approach is known as “One Medicine,” where science benefits both animals and humans. Research into feline cancer could accelerate the search for new therapies and help scientists better understand how tumors develop in humans. The video is for illustrative purposes.

NEXTA

40,255 görüntüleme • 4 ay önce

Trade Talk isn’t here for entertainment. It’s here to give you precision and market awareness like never before. Set your reminders. Space link is in comments. Here’s a clip from Fridays space. Wen alt season? 😏

Trade Talk isn’t here for entertainment. It’s here to give you precision and market awareness like never before. Set your reminders. Space link is in comments. Here’s a clip from Fridays space. Wen alt season? 😏

Clutch (🥷)

31,751 görüntüleme • 1 yıl önce

‼️Dont ignore these early signs of Ovarian Cancer. It is possible to detect #ovariancancer if we are picking up the symptoms early by listening to women and investigating with a transvaginal USS and CA125 blood test **It’s important to know a CA125 and a ultrasound scan can come back normal. So if the tests are normal - STILL continue to track the symptoms and depending on the symptoms, risk factors etc a referral to gynaecologist might be needed for a further investigations such as CT, MRI or a Ovarian biopsy (a procedure where a small sample of tissue from the ovary is removed to check for abnormalities, most commonly to diagnose or stage ovarian cancer)** … thankfully my patient’s Ovarian Cancer was picked up early and now is doing well - post treatment Hope this helps

‼️Dont ignore these early signs of Ovarian Cancer. It is possible to detect #ovariancancer if we are picking up the symptoms early by listening to women and investigating with a transvaginal USS and CA125 blood test It’s important to know a CA125 and a ultrasound scan can come back normal. So if the tests are normal - STILL continue to track the symptoms and depending on the symptoms, risk factors etc a referral to gynaecologist might be needed for a further investigations such as CT, MRI or a Ovarian biopsy (a procedure where a small sample of tissue from the ovary is removed to check for abnormalities, most commonly to diagnose or stage ovarian cancer) … thankfully my patient’s Ovarian Cancer was picked up early and now is doing well - post treatment Hope this helps

𝑫𝒓 𝑵𝒊𝒈𝒉𝒂𝒕 𝑨𝒓𝒊𝒇

25,982 görüntüleme • 8 ay önce

$20B Skin Cancer Market Demands Non-Invasive Solutions – Medicus Delivers | Airing on CNBC and FOX Business What if treating skin cancer didn’t require painful, invasive surgeries? Medicus Pharma Ltd is revolutionizing cancer care with its non-invasive, targeted chemotherapy—delivering treatment directly to tumor sites with minimal discomfort. 🔬 Advancing through Phase 2 clinical studies 📈 Skin cancer treatment market projected to exceed $20B by 2030 💡 A cost-effective, surgery-free solution Medicus Pharma is at the forefront of a new era in oncology, prioritizing patient comfort and treatment efficacy. Learn more about this game-changing innovation: (NASDAQ: $MDCX) #MedicusPharma #SkinCancerTreatment #BiotechInvesting #Biotech #CancerTreatment #SkinCancer #StocksinNews #StockstoBuy

$20B Skin Cancer Market Demands Non-Invasive Solutions – Medicus Delivers | Airing on CNBC and FOX Business What if treating skin cancer didn’t require painful, invasive surgeries? Medicus Pharma Ltd is revolutionizing cancer care with its non-invasive, targeted chemotherapy—delivering treatment directly to tumor sites with minimal discomfort. 🔬 Advancing through Phase 2 clinical studies 📈 Skin cancer treatment market projected to exceed $20B by 2030 💡 A cost-effective, surgery-free solution Medicus Pharma is at the forefront of a new era in oncology, prioritizing patient comfort and treatment efficacy. Learn more about this game-changing innovation: (NASDAQ: $MDCX) #MedicusPharma #SkinCancerTreatment #BiotechInvesting #Biotech #CancerTreatment #SkinCancer #StocksinNews #StockstoBuy

BTV & CEO Clips

18,775 görüntüleme • 1 yıl önce

1 in 11 babies born in America this year will be screened by a genetic test that didn't exist a decade ago. Biotech startup BillionToOne turned a simple but radical idea—detecting rare fragments of fetal DNA in a mother's blood—into one of the most widely used prenatal tests in the U.S. And they're not stopping there. The same approach could unlock something even bigger: early-stage cancer detection from a blood test, a breakthrough that could one day save millions of lives. In this episode of Hard Tech, YC's Jared Friedman sits down with founders David Tsao (David Tsao) and Oguzhan Atay (Oguzhan Atay) to hear how they went from half a lab bench to a $4B biotech company, and why they believe this is just the beginning of what their technology can do. 00:00 – Finding One Mutation in Billions 01:00 – Detecting Disease From a Blood Sample 02:10 – From Lab Idea to $4B Company 03:05 – The Breakthrough That Made It Possible 05:15 – Building the First Test From Scratch 07:30 – One Customer and a Sales Crisis 08:55 – Inside the Lab: How It Actually Works 12:10 – Detecting Cancer From Blood 13:50 – The Path to Early Cancer Detection 16:05 – Why Early Cancer Detection Is So Hard

1 in 11 babies born in America this year will be screened by a genetic test that didn't exist a decade ago. Biotech startup BillionToOne turned a simple but radical idea—detecting rare fragments of fetal DNA in a mother's blood—into one of the most widely used prenatal tests in the U.S. And they're not stopping there. The same approach could unlock something even bigger: early-stage cancer detection from a blood test, a breakthrough that could one day save millions of lives. In this episode of Hard Tech, YC's Jared Friedman sits down with founders David Tsao (David Tsao) and Oguzhan Atay (Oguzhan Atay) to hear how they went from half a lab bench to a $4B biotech company, and why they believe this is just the beginning of what their technology can do. 00:00 – Finding One Mutation in Billions 01:00 – Detecting Disease From a Blood Sample 02:10 – From Lab Idea to $4B Company 03:05 – The Breakthrough That Made It Possible 05:15 – Building the First Test From Scratch 07:30 – One Customer and a Sales Crisis 08:55 – Inside the Lab: How It Actually Works 12:10 – Detecting Cancer From Blood 13:50 – The Path to Early Cancer Detection 16:05 – Why Early Cancer Detection Is So Hard

Y Combinator

98,421 görüntüleme • 3 ay önce

RFK Jr. says he is working with insurance companies to start covering treatment that can cure sickle cell. “I spent the day with a young woman who was in agony because of sickle cell… and she now has a full life because she received this treatment.” “If we can give that to people that’s almost providential power.” “I was in South Carolina inking the final documents on a deal that we've put together… to make this particular cell and gene therapy available to every person in the state who has sickle cell with it being fully paid for.” “We're negotiating now with 38 other states and by the end of next year we hope to have this available to every American.” “It's saving the insurance companies money… if they look at the total cost over the lifetime of that child it's an enormous saving because even though it's a very expensive drug, it's a one time treatment.”

RFK Jr. says he is working with insurance companies to start covering treatment that can cure sickle cell. “I spent the day with a young woman who was in agony because of sickle cell… and she now has a full life because she received this treatment.” “If we can give that to people that’s almost providential power.” “I was in South Carolina inking the final documents on a deal that we've put together… to make this particular cell and gene therapy available to every person in the state who has sickle cell with it being fully paid for.” “We're negotiating now with 38 other states and by the end of next year we hope to have this available to every American.” “It's saving the insurance companies money… if they look at the total cost over the lifetime of that child it's an enormous saving because even though it's a very expensive drug, it's a one time treatment.”

End Tribalism in Politics

35,435 görüntüleme • 1 yıl önce

Dr. Patrick Soon-Shiong calls out a massive blind spot in oncology "99.9% of oncologists ignore the only cells that actually kill cancer: natural killer cells and T-cells (lymphocytes in your CBC). They focus on anemia (red blood cells), low platelets, low neutrophils — but those don’t cure cancer. The real fighters? Completely overlooked in standard care." Eye-opening critique of how cancer treatment misses the immune system. 1:20 clip inside — must-watch for anyone following cancer science.

Dr. Patrick Soon-Shiong calls out a massive blind spot in oncology "99.9% of oncologists ignore the only cells that actually kill cancer: natural killer cells and T-cells (lymphocytes in your CBC). They focus on anemia (red blood cells), low platelets, low neutrophils — but those don’t cure cancer. The real fighters? Completely overlooked in standard care." Eye-opening critique of how cancer treatment misses the immune system. 1:20 clip inside — must-watch for anyone following cancer science.

Camus

199,804 görüntüleme • 6 ay önce

'How frustrating and dangerous it was to be turned away from your GP and told you were 'too young' and what conversations were you having with the doctor about your symptoms?' Susanna Reid and Paul Brand speak to Milli Tanner, who was suffering from stomach and back pains and found blood in her stool, but doctors repeatedly dismissed her symptoms. After 13 visits to a GP, she took matters into her own hands, ordering a bowel cancer test online. She was eventually diagnosed with stage 3 bowel cancer when she was 22.

Good Morning Britain

68,599 görüntüleme • 8 ay önce

Today, we’re taking another step in making it easy to get proactive about your health. Introducing the Hims & Hers Multi-Cancer Test by Galleri®. By combining innovation from GRAIL and the ease of our platform, we’re giving you a way to screen for a signal for 50+ types of cancer in a single blood test. Our Chief Medical Officer, Dr. Pat Carroll, has spent decades as a family physician and has seen the difference earlier access to powerful technology can make for people everywhere. Hear more from him on why we’re so committed to expanding access to proactive care.

Today, we’re taking another step in making it easy to get proactive about your health. Introducing the Hims & Hers Multi-Cancer Test by Galleri®. By combining innovation from GRAIL and the ease of our platform, we’re giving you a way to screen for a signal for 50+ types of cancer in a single blood test. Our Chief Medical Officer, Dr. Pat Carroll, has spent decades as a family physician and has seen the difference earlier access to powerful technology can make for people everywhere. Hear more from him on why we’re so committed to expanding access to proactive care.

Hims & Hers Comms

85,132 görüntüleme • 5 ay önce

The Chemotherapy Paradox – A "Cure" That Preserves the Root of Cancer? You've been told chemotherapy is a cornerstone of cancer care. But what if the standard of care is fundamentally flawed, suppressing the very system designed to heal you while protecting the engine that drives the disease? In a stunning exposition, Dr. Paul Marik pulls back the curtain on oncology's biggest dilemma. Here's the shocking truth: - Chemotherapy annihilates your immune army. It wipes out your natural killer cells and T-cells—the very soldiers your body needs to fight cancer. You are immune-suppressed, allowing the tumor a clearer path to proliferate. - Chemotherapy preserves the cancer stem cell. This is the root of the tumor. While chemo kills rapidly dividing cells, it often leaves the stem cell—the queen bee—untouched. From this root, the cancer indefinitely divides, mutates, and regrows. - Some chemo drugs may even STIMULATE the stem cell. That's right. The very treatment intended to kill cancer can, in some cases, fuel its source. "So you can't cure the patient unless you get rid of the cancer stem cell," states Dr. Marik. "Interestingly, chemotherapy doesn't kill the stem cell." This explains why "remission" is not a "cure." The cancer can return 7, 8, or 10 years later because the root was never addressed. You are in remission, not cured. The conclusion? The high-dose, "burn-and-cut" approach of traditional oncology is not holistic. It weakens the host and empowers the enemy's most resilient forces. Dr. Marik confirms: The efficacy depends on the tumor type. Cancers with a low percentage of stem cells can see long-term remission. But for many, it's a ticking time bomb. This isn't an opinion; it's a biological reality. It’s time for a paradigm shift. Share this to spark a crucial conversation. The future of oncology depends on it.

The Chemotherapy Paradox – A "Cure" That Preserves the Root of Cancer? You've been told chemotherapy is a cornerstone of cancer care. But what if the standard of care is fundamentally flawed, suppressing the very system designed to heal you while protecting the engine that drives the disease? In a stunning exposition, Dr. Paul Marik pulls back the curtain on oncology's biggest dilemma. Here's the shocking truth: - Chemotherapy annihilates your immune army. It wipes out your natural killer cells and T-cells—the very soldiers your body needs to fight cancer. You are immune-suppressed, allowing the tumor a clearer path to proliferate. - Chemotherapy preserves the cancer stem cell. This is the root of the tumor. While chemo kills rapidly dividing cells, it often leaves the stem cell—the queen bee—untouched. From this root, the cancer indefinitely divides, mutates, and regrows. - Some chemo drugs may even STIMULATE the stem cell. That's right. The very treatment intended to kill cancer can, in some cases, fuel its source. "So you can't cure the patient unless you get rid of the cancer stem cell," states Dr. Marik. "Interestingly, chemotherapy doesn't kill the stem cell." This explains why "remission" is not a "cure." The cancer can return 7, 8, or 10 years later because the root was never addressed. You are in remission, not cured. The conclusion? The high-dose, "burn-and-cut" approach of traditional oncology is not holistic. It weakens the host and empowers the enemy's most resilient forces. Dr. Marik confirms: The efficacy depends on the tumor type. Cancers with a low percentage of stem cells can see long-term remission. But for many, it's a ticking time bomb. This isn't an opinion; it's a biological reality. It’s time for a paradigm shift. Share this to spark a crucial conversation. The future of oncology depends on it.

Camus

69,487 görüntüleme • 8 ay önce

Pakistan marks a historic milestone in healthcare with the development of its first state-of-the-art public cancer facility. The Nawaz Sharif Institute of Cancer Treatment and Research, Lahore, completed in record time, is set to transform cancer care across the country. Bringing comprehensive treatment under one roof, from advanced diagnostics and laboratory services to radiology, LINAC-based radiation therapy, and surgery, the institute is equipped with world-class technology and facilities. This is more than a hospital; it is a new era of public service.

Pakistan marks a historic milestone in healthcare with the development of its first state-of-the-art public cancer facility. The Nawaz Sharif Institute of Cancer Treatment and Research, Lahore, completed in record time, is set to transform cancer care across the country. Bringing comprehensive treatment under one roof, from advanced diagnostics and laboratory services to radiology, LINAC-based radiation therapy, and surgery, the institute is equipped with world-class technology and facilities. This is more than a hospital; it is a new era of public service.

Maryam Nawaz Sharif

197,309 görüntüleme • 3 ay önce

Big Pharma Whistleblower Found Dead After Confirming Ivermectin Cures Cancer A veteran physician with over 30 years inside the medical system - specializing in family and emergency medicine - was found dead just days after blowing the whistle on one of the industry’s most explosive secrets: the hidden link between parasites and cancer... and the suppressed cure Big Pharma doesn’t want you to know about - Ivermectin. This is explosive. And the consequences are grave. Because if what Dr. Karen Ruthman uncovered is true, then Big Pharma isn't just failing us - it's actively complicit in sacrificing the health of millions, knowingly suppressing a cure to keep cancer patients locked in a cycle of treatment and profit.

Big Pharma Whistleblower Found Dead After Confirming Ivermectin Cures Cancer A veteran physician with over 30 years inside the medical system - specializing in family and emergency medicine - was found dead just days after blowing the whistle on one of the industry’s most explosive secrets: the hidden link between parasites and cancer... and the suppressed cure Big Pharma doesn’t want you to know about - Ivermectin. This is explosive. And the consequences are grave. Because if what Dr. Karen Ruthman uncovered is true, then Big Pharma isn't just failing us - it's actively complicit in sacrificing the health of millions, knowingly suppressing a cure to keep cancer patients locked in a cycle of treatment and profit.

TPV Sean

111,418 görüntüleme • 1 yıl önce

Israel just took a massive leap in the war on cancer. New Phase developed a revolutionary nanotech treatment that uses specially designed nanoparticles to heat and destroy metastatic tumors from the inside, even in hard-to-reach areas, while sparing healthy tissue. The technology is already showing incredible results in clinical trials for late-stage cancer patients. This is precision medicine at the nanoscale, turning the body’s own biology into a targeted weapon against one of humanity’s deadliest diseases. From the lab to saving lives worldwide, Startup Nation at it again. Proud every single day. 🇮🇱 #StartupNation #IsraeliInnovation #Nanotech #CancerTreatment #NewPhase

Israel just took a massive leap in the war on cancer. New Phase developed a revolutionary nanotech treatment that uses specially designed nanoparticles to heat and destroy metastatic tumors from the inside, even in hard-to-reach areas, while sparing healthy tissue. The technology is already showing incredible results in clinical trials for late-stage cancer patients. This is precision medicine at the nanoscale, turning the body’s own biology into a targeted weapon against one of humanity’s deadliest diseases. From the lab to saving lives worldwide, Startup Nation at it again. Proud every single day. 🇮🇱 #StartupNation #IsraeliInnovation #Nanotech #CancerTreatment #NewPhase

Mor Edge Insight

15,196 görüntüleme • 2 ay önce

A Cancer Revolution Hidden in Plain Sight For 30 years, Dr. Patrick Soon-Shiong has pursued a radical truth—one that could rewrite how we treat cancer. And it’s been inside us all along. The Secret Weapon? Natural Killer (NK) Cells. These microscopic warriors evolved 450 million years ago to protect mammals. Watch this real footage—not animation—of an NK cell devouring a cancer cell. Then, the T-cell joins the fight. Together, they’re our body’s elite defense. The Paradigm Shift: What if cancer isn’t the root disease—but a symptom? A sign of immune collapse as we age or face infections? For decades, medicine has attacked cancer with tools that weaken immunity (chemotherapy, radiation, steroids). But what if we rebuild the immune system instead? The Proof: An FDA-approved therapy (already used for bladder cancer) proliferates NK cells, safely tested in 8,000 doses. This isn’t sci-fi—it’s science. The Mission: Educate the world. Challenge doctors, regulators, and patients to rethink cancer treatment. Because the cure may not come from a lab—but from harnessing what’s already within us. The Future of Medicine Starts Now.

A Cancer Revolution Hidden in Plain Sight For 30 years, Dr. Patrick Soon-Shiong has pursued a radical truth—one that could rewrite how we treat cancer. And it’s been inside us all along. The Secret Weapon? Natural Killer (NK) Cells. These microscopic warriors evolved 450 million years ago to protect mammals. Watch this real footage—not animation—of an NK cell devouring a cancer cell. Then, the T-cell joins the fight. Together, they’re our body’s elite defense. The Paradigm Shift: What if cancer isn’t the root disease—but a symptom? A sign of immune collapse as we age or face infections? For decades, medicine has attacked cancer with tools that weaken immunity (chemotherapy, radiation, steroids). But what if we rebuild the immune system instead? The Proof: An FDA-approved therapy (already used for bladder cancer) proliferates NK cells, safely tested in 8,000 doses. This isn’t sci-fi—it’s science. The Mission: Educate the world. Challenge doctors, regulators, and patients to rethink cancer treatment. Because the cure may not come from a lab—but from harnessing what’s already within us. The Future of Medicine Starts Now.

Camus

49,252 görüntüleme • 11 ay önce

Dr. Patrick Soon-Shiong revealed a game-changing cancer breakthrough on Sean Spicer’s show: “We’ve built the world’s first AI-driven robotic factory that turns a pint of your blood into billions of activated natural killer cells — frozen, ready to infuse in 30 minutes as an outpatient.” Key points from the 2:26 clip: - IL-15 jab supercharges your body to grow NK cells (NCI calls it the most important molecule to cure cancer). - Blood draw → robot grows trillions of targeted NK cells → freeze into doses anyone can receive (like type O blood). - The humanoid robot + AI vision system slashes production cost 10×. - First full-scale unit installs in Los Angeles in ~3 months, second ships to Saudi Arabia. - Goal: become the “American Red Cross of cancer” — mass-produced, affordable NK therapy for the world. Sean Spicer: “It’s embarrassing as an American that we had this first… and the Saudis are going to bring it to market in a much better way.” A potential revolution in cancer treatment — off-the-shelf, engineered NK cells made at scale. What do you think — is this the future of cancer care, or too good to be true?

Dr. Patrick Soon-Shiong revealed a game-changing cancer breakthrough on Sean Spicer’s show: “We’ve built the world’s first AI-driven robotic factory that turns a pint of your blood into billions of activated natural killer cells — frozen, ready to infuse in 30 minutes as an outpatient.” Key points from the 2:26 clip: - IL-15 jab supercharges your body to grow NK cells (NCI calls it the most important molecule to cure cancer). - Blood draw → robot grows trillions of targeted NK cells → freeze into doses anyone can receive (like type O blood). - The humanoid robot + AI vision system slashes production cost 10×. - First full-scale unit installs in Los Angeles in ~3 months, second ships to Saudi Arabia. - Goal: become the “American Red Cross of cancer” — mass-produced, affordable NK therapy for the world. Sean Spicer: “It’s embarrassing as an American that we had this first… and the Saudis are going to bring it to market in a much better way.” A potential revolution in cancer treatment — off-the-shelf, engineered NK cells made at scale. What do you think — is this the future of cancer care, or too good to be true?

Camus

201,645 görüntüleme • 4 ay önce

“One of the most effective treatments for knocking out the cancer stem cell is the famous horse deworming medicine [ivermectin].” That’s Dr. Paul Marik, the second most published critical care physician in the world. He used AI to analyze 38 million papers and rank every known compound against cancer. The top 4, according to the AI, were: 1.) Ivermectin 2.) Mebendazole 3.) Fenbendazole 4.) Turmeric NOTE: Views expressed in this video are those of the host and the guest and do not necessarily reflect the views of The Epoch Times. This content is for informational purposes only and is not medical advice. Consult with your doctor before starting any new treatment for any condition or disease.

“One of the most effective treatments for knocking out the cancer stem cell is the famous horse deworming medicine [ivermectin].” That’s Dr. Paul Marik, the second most published critical care physician in the world. He used AI to analyze 38 million papers and rank every known compound against cancer. The top 4, according to the AI, were: 1.) Ivermectin 2.) Mebendazole 3.) Fenbendazole 4.) Turmeric NOTE: Views expressed in this video are those of the host and the guest and do not necessarily reflect the views of The Epoch Times. This content is for informational purposes only and is not medical advice. Consult with your doctor before starting any new treatment for any condition or disease.

Epoch Health

17,603 görüntüleme • 1 ay önce